Loading fund overlap…
15 of 165 unique stocks in common · Jaccard: 9.1%
A weighted portfolio overlap of 12.4% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹12.4 is allocated to the exact same companies at the same relative proportions. The schemes share 15 common holdings.
The largest overlapping asset in their portfolios is Gland Pharma, which commands a weight of 1.61% in DSP Small Cap Fund and 1.85% in Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF. Holding both schemes increases your concentration in Gland Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in DSP | in Mirae |
|---|---|---|
| Gland PharmaPharmaceuticals & Biotechnology | 1.61% | 1.85% |
| Welspun CorpIndustrial Products | 2.56% | 1.52% |
| Navin Fluorine InternationalChemicals & Petrochemicals | 1.40% | 3.60% |
| Amber Enterprises IndiaConsumer Durables | 0.95% | 1.46% |
| eClerx ServicesCommercial Services & Supplies | 1.82% | 0.95% |
| PNB Housing FinanceFinance | 1.43% | 0.87% |
| Anand Rathi WealthCapital Markets | 0.76% | 3.31% |
| Narayana HrudayalayaHealthcare Services | 0.74% | 1.75% |
| Eris LifesciencesPharmaceuticals & Biotechnology | 0.94% | 0.62% |
| Manappuram FinanceFinance | 0.59% | 2.89% |
| Angel OneCapital Markets | 0.58% | 2.20% |
| CyientIT - Services | 1.48% | 0.54% |
| LT FoodsAgricultural Food & Other Products | 2.14% | 0.46% |
| Techno Electric & Engineering CompanyConstruction | 1.47% | 0.43% |
| Engineers IndiaConstruction | 0.38% | 0.57% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.